Hyperbaric Oxygen Therapy for Long COVID: What the Research Shows
At a Glance
- What it is: Pressurized-chamber oxygen therapy (1.5-2.0 ATA) applied over 40-60 sessions to address persistent Long COVID symptoms.
- Key evidence: A 2022 Israeli randomized controlled trial demonstrated significant cognitive and fatigue improvements in Long COVID patients after HBOT.
- Best for: Brain fog, chronic fatigue, exercise intolerance, and neurological symptoms that have persisted 3+ months post-infection.
- Protocol: Typically 40-60 sessions, five days per week, 90 minutes each at 2.0 ATA with 100% oxygen.
- Cost: $6,000-$15,000 for a full course; generally not covered by insurance for Long COVID.
If you have been navigating the fog, fatigue, and frustration of Long COVID, you already know how limited the treatment options feel. Most conventional approaches amount to “rest more, pace yourself, and wait.” For millions of people still struggling months or even years after their initial infection, that advice rings hollow.
Hyperbaric oxygen therapy, HBOT, has emerged as one of the more scientifically grounded interventions for Long COVID. Unlike many alternative treatments that rely on theory alone, HBOT for Long COVID now has randomized controlled trial data behind it. That does not mean it is a guaranteed cure, but it does mean the conversation has moved beyond speculation.
Let us walk through what the research actually shows, how the mechanism works, what a treatment course looks like, and how HBOT stacks up against other Long COVID interventions.
The Landmark Israeli RCT: Zilberman-Itskovich 2022
The study that put HBOT for Long COVID on the clinical map was published in Scientific Reports in 2022 by Dr. Shai Efrati and colleagues at the Sagol Center for Hyperbaric Medicine in Israel. This was not a case study or a retrospective chart review, it was a randomized, double-blind, sham-controlled trial, which is the gold standard in clinical research.
Here is what the study looked like:
- 73 patients with confirmed Long COVID symptoms lasting at least 3 months post-infection
- Patients randomized to either 40 sessions of HBOT at 2.0 ATA with 100% oxygen or a sham treatment (room air at 1.0 ATA)
- Sessions lasted 90 minutes each, five days per week
- Outcomes measured included cognitive function, psychiatric symptoms, pain, and quality of life
The results were striking. The HBOT group showed statistically significant improvements in:
- Global cognitive function, particularly attention and executive function
- Energy levels and fatigue severity
- Psychiatric symptoms, including depression and anxiety scores
- Pain interference with daily activities
Brain imaging (MRI perfusion studies) also showed measurable increases in cerebral blood flow in brain regions associated with the reported cognitive improvements. This is important because it provides an objective biomarker that corroborates the subjective symptom improvement.
How HBOT Works for Long COVID: The Mechanism
Long COVID is increasingly understood as a condition involving microvasculature damage, neuroinflammation, and tissue hypoxia, meaning the smallest blood vessels are impaired, the brain is inflamed, and tissues are not getting enough oxygen even though you are breathing normally.
HBOT addresses these issues through several interconnected mechanisms:
1. Tissue Reoxygenation
Under pressure, oxygen dissolves directly into plasma at concentrations far above what hemoglobin alone can deliver. This hyperoxic state reaches tissues that damaged microvasculature cannot supply through normal circulation. For Long COVID patients with subtle perfusion deficits in the brain and other organs, this can be transformative.
2. Neuroplasticity Stimulation
HBOT has been shown to stimulate angiogenesis (new blood vessel formation) and neurogenesis (new neural connections). The intermittent hyperoxia-normoxia cycling that occurs during repeated sessions triggers the release of growth factors, including VEGF and BDNF, that promote brain repair and neuroplasticity.
3. Anti-Inflammatory Effects
HBOT downregulates inflammatory cytokines and modulates immune function. Given that Long COVID involves persistent immune dysregulation, sometimes described as a “cytokine echo” of the original infection, this anti-inflammatory action may help reset the immune system toward normal function.
4. Mitochondrial Recovery
Emerging research suggests Long COVID damages mitochondrial function, contributing to the profound fatigue patients experience. HBOT supports mitochondrial repair and biogenesis, potentially restoring cellular energy production.
What Symptoms Respond Best to HBOT?
Not all Long COVID symptoms are equally responsive to HBOT. Based on the available evidence and clinical experience, here is how different symptoms tend to respond:
| Symptom | Response to HBOT | Evidence Level |
|---|---|---|
| Brain fog / cognitive dysfunction | Strong improvement | RCT data (Zilberman-Itskovich 2022) |
| Chronic fatigue | Moderate to strong improvement | RCT data |
| Exercise intolerance | Moderate improvement | Observational + RCT |
| Depression / anxiety | Moderate improvement | RCT data |
| Shortness of breath | Variable | Case series only |
| Autonomic dysfunction (POTS) | Limited data | Anecdotal reports |
The strongest evidence points toward neurological and cognitive symptoms as the primary beneficiaries of HBOT. This makes sense mechanistically, since the brain is particularly sensitive to oxygen deprivation and HBOT delivers the most dramatic improvements in cerebral oxygenation.
The HBOT Protocol for Long COVID
The treatment protocol used in the Israeli RCT, and adopted by most clinics offering HBOT for Long COVID, follows this general structure:
- Pressure: 2.0 ATA (atmospheres absolute), equivalent to being approximately 33 feet underwater
- Oxygen: 100% medical-grade oxygen delivered via mask or hood
- Session duration: 90 minutes of pressurized treatment (plus approximately 15 minutes for compression and decompression)
- Frequency: 5 sessions per week (Monday through Friday)
- Total sessions: 40 sessions minimum; some protocols extend to 60 sessions for more severe cases
- Total treatment time: 8-12 weeks
Cost Analysis: What HBOT for Long COVID Actually Costs
HBOT is a significant financial investment, especially since insurance typically does not cover it for Long COVID. Here is a realistic cost breakdown:
- Per-session cost: $150-$350 per session at most freestanding clinics
- 40-session course: $6,000-$14,000
- 60-session course: $9,000-$21,000
- Initial evaluation: $150-$500 (physician consultation, sometimes including imaging)
- Follow-up assessments: $100-$300 per visit
Some clinics offer package pricing that reduces the per-session cost by 10-20% when you commit to a full treatment course upfront. A few clinics also offer financing options or membership plans.
The total out-of-pocket cost for a typical 40-session protocol, including evaluations, ranges from $7,000 to $15,000.
HBOT vs. Other Long COVID Treatments
How does HBOT compare to other interventions being used for Long COVID? Here is an honest comparison:
| Treatment | Evidence Level | Cost | Best For |
|---|---|---|---|
| HBOT | RCT data (moderate) | $7,000-$15,000 | Brain fog, fatigue, cognitive issues |
| Pacing / Activity Management | Expert consensus | Free-$200/mo (coaching) | PEM prevention, energy management |
| Low-Dose Naltrexone (LDN) | Case series, small trials | $30-$80/month | Neuroinflammation, fatigue, pain |
| NAD+ IV Therapy | Preclinical + anecdotal | $2,000-$6,000 (course) | Energy, mitochondrial support |
| Graded Exercise Therapy | Controversial (may worsen PEM) | $100-$300/mo (PT) | Deconditioning (without PEM) |
HBOT has the strongest clinical trial evidence of any intervention on this list, but it is also by far the most expensive and time-intensive. For many patients, a practical approach involves starting with lower-cost interventions like pacing and LDN, and considering HBOT if cognitive and fatigue symptoms remain debilitating.
Who Is a Good Candidate for HBOT?
Based on the research and clinical experience, the best candidates for HBOT for Long COVID tend to be:
- Patients with prominent cognitive symptoms (brain fog, word-finding difficulty, memory problems)
- Those with persistent fatigue that has not responded to rest, pacing, and basic interventions
- Patients who are at least 3 months post-acute infection (to distinguish from normal recovery)
- People who can commit to the time and financial investment of a full treatment course
- Those without contraindications to HBOT (untreated pneumothorax, certain seizure disorders, active middle ear infections)
HBOT is probably not the best first-line choice for patients whose primary symptoms are autonomic (POTS, heart rate variability issues) or primarily respiratory, as the evidence for these specific symptoms is much weaker.
Frequently Asked Questions
How quickly do Long COVID patients notice improvement with HBOT?
Most patients in the Israeli trial began noticing improvements around sessions 15-20, with continued gains through the full 40-session course. Some patients report subtle energy improvements earlier, but significant cognitive gains typically require multiple weeks of consistent treatment. It is important to commit to the full protocol rather than stopping after a few sessions.
Can I use a home hyperbaric chamber for Long COVID?
Home “mild” hyperbaric chambers (1.3 ATA, ambient air) are not equivalent to the medical-grade treatment studied in the RCT (2.0 ATA, 100% oxygen). While some patients report anecdotal benefits from mild HBOT, there is no controlled evidence supporting home chambers for Long COVID. The oxygen delivery at 1.3 ATA with ambient air is dramatically lower than at 2.0 ATA with pure oxygen.
Is HBOT for Long COVID covered by insurance?
In the vast majority of cases, no. Insurance typically covers HBOT only for FDA-cleared indications such as decompression sickness, carbon monoxide poisoning, non-healing diabetic wounds, and radiation injury. Long COVID is not currently an FDA-cleared indication for HBOT, so treatment is almost always out-of-pocket. Some patients have had success appealing denials with supporting documentation from their physician.
Are there any risks or side effects of HBOT for Long COVID patients?
HBOT is generally considered safe when administered in a properly supervised clinical setting. The most common side effects are ear and sinus pressure (barotrauma), temporary myopia (nearsightedness), and mild fatigue after sessions. Serious complications like oxygen toxicity seizures are extremely rare at the pressures used for Long COVID treatment (approximately 1 in 10,000 sessions). Some Long COVID patients report a temporary increase in fatigue during the first week of treatment before improvements begin.
Related Reading
This article is part of our thorough guide to hyperbaric oxygen therapy. For a complete overview of how HBOT works, its applications, and what to expect during treatment, see our pillar article: Hyperbaric Oxygen Therapy: The Complete Guide.
